Newsletters
The Capitalist Newsletter – December 21, 2016
ROGUE ONE BLASTS DISNEY INTO NEW TERRITORY; BECOMES FIRST STUDIO TO GROSS $7 BILLION |
|
Winners & Losers – Conatus Pharmaceuticals, Inc. (CNAT) Skyrockets UP (141.33%) After Completing Licensing Deal with Novartis on Liver Drug – Sucampo Pharmaceuticals, Inc. (SCMP) Falls DOWN (20.51%) After Company Announces Intention to Sell $259 Million in Debt
Most Talked About Fred’s, Inc. (FRED) a Slight Majority Strong Buy After Spiking UP (81.08%) Following its Agreement to Purchase 865 Rite Aid Stores
The TIP Sheets – Tuesday, December 20th – Fred’s, Inc. (FRED) Jumps UP (81.08%) and Rite Aid Corporation (RAD) Ticks UP (5.39%) After Announcing Fred’s Will Purchase 865 Rite Aid Stores. Expect Shares of Both Companies to Continue UP
Unusual Volume
– ACADIA Pharmaceuticals, Inc. (ACAD) Jumps UP (12.35%) on 18.5m Shares Traded After Reporting the Company Met Primary Endpoints in a Critical Phase 2 Drug Trial to Treat Alzheimer’s Psychosis. The FDA has Not Yet Approved ANY Drug to Treat Alzheimer’s Psychosis, so if This Passes, Expect Shares to Rocket UP |